Gordon Y C Cheung1, Michael Otto. 1. Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Abstract
PURPOSE OF REVIEW: This article provides an overview of Staphylococcus epidermidis bacteremia/sepsis and coagulase-negative staphylococci (CoNS) infections in neonates and children. RECENT FINDINGS: The incidence of S. epidermidis and CoNS sepsis in neonates is still very high and preventing and treating disease remains difficult. There has been recent progress in understanding the pathogenesis of S. epidermidis infection, interaction of S. epidermidis with host defenses, and risk factors for the development of S. epidermidis disease. For example, we have gained more insight into the development of biofilm-associated catheter infections, which are responsible for recurrent CoNS infections in hospitalized premature neonates and are especially difficult to treat owing to intrinsic resistance of biofilms to antibiotics. SUMMARY: Biofilm-associated catheter infections by S. epidermidis occur frequently in neonates and adults. S. epidermidis bloodstream infections are particularly problematic in neonates. Prophylaxis in the form of eradicating colonizing S. epidermidis may be a double-edged sword, as S. epidermidis colonization may be beneficial to the host. New drugs may arise from a better understanding of S. epidermidis virulence and analysis of risk factors may help identify neonates susceptible to bacterial sepsis. However, reducing morbidity should always begin by increasing hygiene in hospital settings to reduce the introduction of potentially harmful opportunistic pathogens such as S. epidermidis on indwelling medical devices or during surgery.
PURPOSE OF REVIEW: This article provides an overview of Staphylococcus epidermidis bacteremia/sepsis and coagulase-negative staphylococci (CoNS) infections in neonates and children. RECENT FINDINGS: The incidence of S. epidermidis and CoNS sepsis in neonates is still very high and preventing and treating disease remains difficult. There has been recent progress in understanding the pathogenesis of S. epidermidis infection, interaction of S. epidermidis with host defenses, and risk factors for the development of S. epidermidis disease. For example, we have gained more insight into the development of biofilm-associated catheter infections, which are responsible for recurrent CoNS infections in hospitalized premature neonates and are especially difficult to treat owing to intrinsic resistance of biofilms to antibiotics. SUMMARY: Biofilm-associated catheter infections by S. epidermidis occur frequently in neonates and adults. S. epidermidis bloodstream infections are particularly problematic in neonates. Prophylaxis in the form of eradicating colonizing S. epidermidis may be a double-edged sword, as S. epidermidis colonization may be beneficial to the host. New drugs may arise from a better understanding of S. epidermidis virulence and analysis of risk factors may help identify neonates susceptible to bacterial sepsis. However, reducing morbidity should always begin by increasing hygiene in hospital settings to reduce the introduction of potentially harmful opportunistic pathogens such as S. epidermidis on indwelling medical devices or during surgery.
Authors: Nathan P Wiederhold; Elizabeth A Coyle; Issam I Raad; Randall A Prince; Russell E Lewis Journal: J Antimicrob Chemother Date: 2005-04-06 Impact factor: 5.790
Authors: Patrice Francois; Patrick H Tu Quoc; Carmelo Bisognano; William L Kelley; Daniel P Lew; Jacques Schrenzel; Sarah E Cramton; Friedrich Götz; Pierre Vaudaux Journal: FEMS Immunol Med Microbiol Date: 2003-03-20
Authors: Jong Hee Hwang; Chang Won Choi; Yun Sil Chang; Yon Ho Choe; Won Soon Park; Son Moon Shin; Munhyang Lee; Sang Il Lee Journal: J Korean Med Sci Date: 2005-04 Impact factor: 2.153
Authors: Peter A Smith; Michael E Powers; Tucker C Roberts; Floyd E Romesberg Journal: Antimicrob Agents Chemother Date: 2010-12-28 Impact factor: 5.191